Michael W. Marlatt

1.5k total citations
24 papers, 1.3k citations indexed

About

Michael W. Marlatt is a scholar working on Physiology, Developmental Neuroscience and Pharmacology. According to data from OpenAlex, Michael W. Marlatt has authored 24 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 7 papers in Developmental Neuroscience and 4 papers in Pharmacology. Recurrent topics in Michael W. Marlatt's work include Alzheimer's disease research and treatments (12 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Michael W. Marlatt is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Michael W. Marlatt collaborates with scholars based in United States, Netherlands and United Kingdom. Michael W. Marlatt's co-authors include Paul J. Lucassen, Henriette van Praag, Michelle Potter, Mark A. Smith, George Perry, Xiongwei Zhu, Yury G. Kaminsky, Еlena Kosenko, Gemma Casadesús and Hyoung‐gon Lee and has published in prestigious journals such as Brain Research, Annals of the New York Academy of Sciences and Journal of Neurochemistry.

In The Last Decade

Michael W. Marlatt

21 papers receiving 1.2k citations

Peers

Countries citing papers authored by Michael W. Marlatt

Since Specialization

Citations

This map shows the geographic impact of Michael W. Marlatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Marlatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Marlatt more than expected).

Fields of papers citing papers by Michael W. Marlatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Marlatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Marlatt. The network helps show where Michael W. Marlatt may publish in the future.

Co-authorship network of co-authors of Michael W. Marlatt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Marlatt. A scholar is included among the top collaborators of Michael W. Marlatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Marlatt. Michael W. Marlatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proliferation in the Alzheimer Hippocampus Is due to Microglia, Not Astroglia, and Occurs at Sites of Amyloid Deposition 2014 ·Neural Plasticity ·Michael W. Marlatt, Jan Bauer, Eleonora Aronica, Elise S. van Haastert, Jeroen J.M. Hoozemans, Marian Joëls, Paul J. Lucassen	71
2	Prolonged Running, not Fluoxetine Treatment, Increases Neurogenesis, but does not Alter Neuropathology, in the 3xTg Mouse Model of Alzheimer’s Disease 2013 ·Current topics in behavioral neurosciences ·Michael W. Marlatt, Michelle Potter, Thomas A. Bayer, Henriette van Praag, Paul J. Lucassen	81
3	Running throughout middle‐age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice 2012 ·Developmental Neurobiology ·Michael W. Marlatt, Michelle Potter, Paul J. Lucassen, Henriette van Praag	258
4	Distinct structural plasticity in the hippocampus and amygdala of the middle-aged common marmoset (Callithrix jacchus) 2011 ·Experimental Neurology ·Michael W. Marlatt, Ingrid H.C.H.M. Philippens, Erik M. M. Manders, Boldizsár Czéh, Marian Joëls, Harm J. Krugers, Paul J. Lucassen	48
5	Neurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men 2010 ·Current Alzheimer Research ·Michael W. Marlatt, Paul J. Lucassen	76
6	Presenilin mouse and zebrafish models for dementia: Focus on neurogenesis 2010 ·Progress in Neurobiology ·Paula van Tijn, Willem Kamphuis, Michael W. Marlatt, Elly M. Hol, Paul J. Lucassen	29
7	Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice 2010 ·Brain Research ·Michael W. Marlatt, Paul J. Lucassen, Henriette van Praag	75
8	Induction of Alzheimer’s-like changes in brain of mice expressing mutant APP fed excess methionine 2010 ·Journal of Neurochemistry ·Alexander McCampbell, (unknown), Michael W. Marlatt, (unknown), Dawn Toolan, Alexei A. Podtelezhnikov, Suzie Yeh, Rena Zhang, (unknown), Keith Q. Tanis, John Majercak, William J. Ray, Mary J. Savage	19
9	Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease 2010 ·International Journal of Biomedical Science ·George Perry, Hyoung‐gon Lee, Hyun Pil Lee, Xiongwei Zhu, Mark A. Smith, Raj K. Rolston, Michael W. Marlatt, Rudy J. Castellani, Akihiko Nunomura, Gemma Casadesús, Timothy Clark	58
10	Treatment advances in Alzheimer's disease based on the oxidative stress model 2009 ·F1000 Medicine Reports ·Avi L. Friedlich, Raj K. Rolston, Xiongwei Zhu, Michael W. Marlatt, Rudy J. Castellani, Akihiko Nunomura, Hyoung‐gon Lee, Gemma Casadesús, George Perry, Mark A. Smith	1
11	Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35 2009 ·Experimental Neurology ·Yury G. Kaminsky, Michael W. Marlatt, Mark A. Smith, Еlena Kosenko	146
12	Alzheimer’s Disease and Adult Neurogenesis—Are Endogenous Stem Cells Part of the Solution? 2009 ·Michael W. Marlatt, Jeroen J.M. Hoozemans, Rob Veerhuis, Paul J. Lucassen	0
13	The Application of Microarray Technology to Neuropathology: Cutting Edge Tool With Clinical Diagnostics Potential or Too Much Information? 2006 ·Journal of Neuropathology & Experimental Neurology ·Andrew McShea, Michael W. Marlatt, Hyoung‐gon Lee, (unknown), (unknown), Mark A. Smith	8
14	Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis 2005 ·Annals of the New York Academy of Sciences ·Kate M. Webber, Gemma Casadesús, Michael W. Marlatt, George Perry, Clive R. Hamlin, Craig Atwood, Richard L. Bowen, Mark A. Smith	37
15	Therapeutic Opportunities in Alzheimer Disease: One for all or all for One? 2005 ·Current Medicinal Chemistry ·Michael W. Marlatt, Kate Webber, Paula I. Moreira, Hyoung‐gon Lee, Gemma Casadesús, Kazuhiro Honda, Xiongwei Zhu, George Perry, (unknown)	33
16	The cell cycle in Alzheimer disease: A unique target for neuropharmacology 2005 ·Mechanisms of Ageing and Development ·Kate M. Webber, Arun K. Raina, Michael W. Marlatt, Xiongwei Zhu, (unknown), Laura Morelli, Gemma Casadesús, George Perry, Mark A. Smith	78
17	The Calamity of the Initial Reserve Surveys under the Robinson Treaties 2004 ·Michael W. Marlatt	0
18	Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease 2004 ·Acta Neurobiologiae Experimentalis ·Michael W. Marlatt, Hyoung‐gon Lee, George Perry, Mark Smith, Xiongwei Zhu	42
19	Mitotic and Gender Parallels in Alzheimer Disease: Therapeutic Opportunities 2004 ·Current Drug Targets ·Xiongwei Zhu, Kate Webber, Gemma Casadesús, Ashok K. Raina, Hyoung‐gon Lee, Michael W. Marlatt, Andrea L. Hartzler, Craig Atwood, Richard A. Bowen, (unknown), Mark A. Smith	5
20	The role of metabotropic glutamate receptors in Alzheimer's disease 2004 ·Acta Neurobiologiae Experimentalis ·Hyoung‐gon Lee, Xiongwei Zhu, Michael O’Neill, Kate M. Webber, Gemma Casadesús, Michael W. Marlatt, Arun K. Raina, George Perry, (unknown)	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact